13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001601086
Total reported value
$8.2B
$8.2B
222 檔
40.5%
In Q1 2025, Armistice Capital, LLC's U.S. equity holdings reached a combined market value of $8.2B, distributed across 222 disclosed stock positions.
In Q1 2025, Armistice Capital, LLC displayed an active expansion posture, initiating 105 new positions and adding to 8 existing holdings, outstripping position reductions.
Showing top 200 holdings (of 222 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 20.54% | +4.96% | -2.00% | |
| 2 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 20.03% | +5.89% | -1.47% | |
| 3 | PTCT | Ptc Therapeutics Inc | Stock-Healthcare | 4.15% | -1.26% | -14.79% | |
| 4 | SUPN | Supernus Pharmaceuticals Inc | Stock-Healthcare | 2.55% | -0.23% | +7.44% | |
| 5 | TVTX | Travere Therapeutics Inc | Stock-Other | 2.38% | -1.15% | +20.58% | |
| 6 | CYTK | Cytokinetics Inc | Stock-Healthcare | 2.24% | -0.27% | +93.72% | |
| 7 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 2.16% | -0.57% | +335.88% | |
| 8 | NBIX | Neurocrine Biosciences Inc | Stock-Healthcare | 1.66% | -0.60% | +12.13% | |
| 9 | INCY | Incyte CORP | Stock-Healthcare | 1.52% | +0.15% | -5.45% | |
| 10 | IMVT | Immunovant Inc | Stock-Other | 1.38% | -1.03% | +3.44% | |
| 11 | EXK | Exact Sciences CORP | Stock-Materials | 1.15% | — | +9.61% | |
| 12 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 1.08% | +0.19% | +306.75% | |
| 13 | GRFS | Grifols Sa-adr | Stock-Other | 0.99% | -0.18% | -7.55% | |
| 14 | AGIO | Agios Pharmaceuticals Inc | Stock-Other | 0.90% | -1.19% | -9.55% | |
| 15 | FRPT | Freshpet Inc | Stock-Consumer Staples | 0.89% | -0.24% | — | |
| 16 | ARGX | Argenx Se - Adr | Stock-Healthcare | 0.87% | — | -20.97% | |
| 17 | FIVN | Five9 Inc | Stock-Tech | 0.85% | -0.37% | +6.49% | |
| 18 | STAA | Staar Surgical Co | Stock-Other | 0.79% | — | +244.04% | |
| 19 | TMCI | Treace Medical Concepts Inc | Stock-Other | 0.78% | +0.16% | +0.03% | |
| 20 | PENN | Penn Entertainment Inc | Stock-Consumer Disc | 0.75% | -0.48% | -6.43% | |
| 21 | SAM | Boston Beer Company Inc-a | Stock-Consumer Staples | 0.75% | — | +72.68% | |
| 22 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 0.75% | -0.14% | +42.69% | |
| 23 | SNN | Smith & Nephew PLC -spon Adr | Stock-Other | 0.75% | — | +258.10% | |
| 24 | MSFT | Microsoft CORP | Stock-Tech | 0.74% | +0.05% | +37.55% | |
| 25 | SPB | Spectrum Brands Holdings Inc | Stock-Other | 0.74% | — | +20.00% | |
| 26 | MDT | Medtronic plc | Stock-Healthcare | 0.73% | — | NEW | |
| 27 | OFIX | Orthofix Medical Inc | Stock-Other | 0.72% | -0.19% | -1.20% | |
| 28 | SMPL | Simply Good Foods Co/the | Stock-Other | 0.70% | — | +14.03% | |
| 29 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 0.69% | -0.06% | +40.17% | |
| 30 | XRAY | Dentsply Sirona Inc | Stock-Healthcare | 0.67% | -0.14% | -14.27% | |
| 31 | KURA | Kura Oncology Inc | Stock-Other | 0.65% | -0.05% | +13.31% | |
| 32 | ADBE | Adobe Inc | Stock-Tech | 0.64% | — | +63.50% | |
| 33 | DPZ | Domino's Pizza Inc | Stock-Consumer Disc | 0.62% | — | +80.63% | |
| 34 | SXT | Sensient Technologies CORP | Stock-Materials | 0.61% | — | NEW | |
| 35 | BHVN | Biohaven Ltd. | Stock-Other | 0.60% | — | +0.07% | |
| 36 | AUPH | Aurinia Pharmaceuticals Inc | Stock-Other | 0.60% | — | -21.88% | |
| 37 | KDP | Keurig Dr Pepper Inc | Stock-Consumer Staples | 0.56% | — | — | |
| 38 | S | Sentinelone Inc -class A | Stock-Tech | 0.51% | -0.23% | +0.79% | |
| 39 | ENR | Energizer Holdings Inc | Stock-Other | 0.51% | -0.35% | EXIT | |
| 40 | PLNT | Planet Fitness Inc - Cl A | Stock-Consumer Disc | 0.50% | — | +54.51% | |
| 41 | CENTA | Central Garden And Pet Co-a | Stock-Other | 0.50% | -0.03% | +28.82% | |
| 42 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.44% | — | — | |
| 43 | SNY | Sanofi-adr | Stock-Healthcare | 0.44% | +0.30% | -58.01% | |
| 44 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 0.43% | -0.09% | -18.50% | |
| 45 | DYN | Dyne Therapeutics Inc | Stock-Other | 0.43% | -0.18% | +186.98% | |
| 46 | AVNS | Avanos Medical Inc | Stock-Other | 0.43% | -0.50% | EXIT | |
| 47 | TOST | Toast Inc-class A | Stock-Tech | 0.43% | +0.01% | +12.53% | |
| 48 | TXRH | Texas Roadhouse Inc | Stock-Consumer Disc | 0.41% | +0.02% | NEW | |
| 49 | RIGL | Rigel Pharmaceuticals Inc | Stock-Other | 0.41% | +0.18% | +31.60% | |
| 50 | PRTA | Prothena Corporation plc | Stock-Other | 0.41% | -0.08% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PTCT | Ptc Therapeutics Inc | +2.6% | -14.79% | Add |
| 2 | MDGL | Madrigal Pharmaceuticals Inc | +1.1% | +335.88% | Trim |
| 3 | TVTX | Travere Therapeutics Inc | +0.9% | +20.58% | Add |
| 4 | SUPN | Supernus Pharmaceuticals Inc | +0.7% | +7.44% | Add |
| 5 | MSFT | Microsoft CORP | +0.3% | +37.55% | Add |
| 6 | NOMD | Nomad Foods Limited | +0.2% | -38.77% | Add |
| 7 | INCY | Incyte CORP | +0.1% | -5.45% | Add |
| 8 | ARGX | Argenx Se - Adr | -0.1% | -20.97% | Trim |
| 9 | BIO | Bio-rad Laboratories-a | -0.2% | — | Trim |
| 10 | MDT | Medtronic plc | -0.4% | -27.85% | Add |
| 11 | ENR | Energizer Holdings Inc | -0.5% | +14.02% | Trim |
| 12 | REGN | Regeneron Pharmaceuticals | -0.5% | +306.75% | Trim |
| 13 | ROST | Ross Stores Inc | -0.5% | -28.66% | Trim |
| 14 | ORLY | O'reilly Automotive Inc | -0.5% | -8.11% | Trim |
| 15 | PFE | Pfizer Inc | -0.6% | — | Trim |
| 16 | UBER | Uber Technologies Inc | -0.7% | -29.74% | Trim |
| 17 | AMZN | Amazon.com Inc | -0.8% | +42.69% | Add |
| 18 | VRTX | Vertex Pharmaceuticals Inc | -1.8% | -77.68% | Trim |
| 19 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | New buy |
| 20 | IWM | Ishares Russell 2000 ETF | — | NEW | New buy |
| 21 | ✓ | Spdr S&P 500 Etf Tr Put Option | — | EXIT | Sold out |
| 22 | ✓ | Ishares Tr | — | EXIT | Sold out |
| 23 | CYTK | Cytokinetics Inc | — | NEW | New buy |
| 24 | ✓ | Cerecor Inc | — | EXIT | Sold out |
| 25 | BIIB | Biogen Inc | — | EXIT | Sold out |
| 26 | BMY | Bristol-myers Squibb Co | — | EXIT | Sold out |
| 27 | NBIX | Neurocrine Biosciences Inc | — | NEW | New buy |
| 28 | MRTXEUR | Mirati Therapeutics Inc | — | EXIT | Sold out |
| 29 | ALKS | Alkermes plc | — | EXIT | Sold out |
| 30 | IMVT | Immunovant Inc | — | NEW | New buy |
| 31 | ENTA | Enanta Pharmaceuticals Inc | — | EXIT | Sold out |
| 32 | IOVA | Iovance Biotherapeutics Inc | — | EXIT | Sold out |
| 33 | BURL | Burlington Stores Inc | — | EXIT | Sold out |
| 34 | EXK | Exact Sciences CORP | — | NEW | New buy |
| 35 | ZYMEUSD | Zymeworks Inc | — | EXIT | Sold out |
| 36 | GRFS | Grifols Sa-adr | — | NEW | New buy |
| 37 | AGIO | Agios Pharmaceuticals Inc | — | NEW | New buy |
| 38 | CPB | THE Campbell's Company | — | EXIT | Sold out |
| 39 | FRPT | Freshpet Inc | — | NEW | New buy |
| 40 | ✓ | — | EXIT | Sold out | |
| 41 | VNDA | Vanda Pharmaceuticals Inc | — | EXIT | Sold out |
| 42 | CPRX | Catalyst Pharmaceuticals Inc | — | EXIT | Sold out |
| 43 | FIVN | Five9 Inc | — | NEW | New buy |
| 44 | LULU | Lululemon Athletica Inc | — | EXIT | Sold out |
| 45 | STAA | Staar Surgical Co | — | NEW | New buy |
| 46 | TMCI | Treace Medical Concepts Inc | — | NEW | New buy |
| 47 | PENN | Penn Entertainment Inc | — | NEW | New buy |
| 48 | SAM | Boston Beer Company Inc-a | — | NEW | New buy |
| 49 | SNN | Smith & Nephew PLC -spon Adr | — | NEW | New buy |
| 50 | CLX | Clorox Company | — | EXIT | Sold out |
According to official SEC Form 13F filings, Armistice Capital, LLC reported a total U.S. public equity portfolio value of $8.2B across 222 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, IWM, PTCT) accounted for 40.5% of total reported equity market value during Q1 2025.
Top New Position Initiated
SPY
市值: $1.4B
Top Position Liquidated / Trimmed
Spdr S&P 500 Etf Tr Put Option
前期市值: $1.2B
During Q1 2025, Armistice Capital, LLC's top holdings by market value included SPY (20.5%)、IWM (20.0%)、PTCT (4.2%). The largest single position, SPY, represented 20.5% of total portfolio value.
In Q1 2025, Armistice Capital, LLC made 200 total portfolio adjustments, initiating 105 new buys, adding to 8 positions, trimming 10 holdings, and fully liquidating 77 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.